TDD to Use Inform Genomics' Technology in Drug Development Services | GenomeWeb

NEW YORK (GenomeWeb) – Inform Genomics and Translational Drug Development today announced a collaboration in which TDD will offer Inform's technology and analytic capabilities as part of its drug development services for biopharmaceutical firms. Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.